Ying Shi

Ying Shi,
M.D., Ph.D.
EDUCATION:
9/2005 – 6/2010    Ph.D in Microbiology.  
State Key Laboratory of Pathogen and Biosecurity,
Beijing Institute of Microbiology and Epidemiology
9/2000-7/2003     Master of Biochemistry and Molecular Biology.
Dalian Medical University
9/1994-7/1999     Bachelor of Medicine (equivalent to MD).  
Dalian Medical University,
Working Experience:
2016-now        Researcher
               Beijing Institute of Hepatology, Beijing You'an Hospital, Capital
Medical University
2012-2016        Associated Researcher
                Beijing Institute of Hepatology, Beijing You'an Hospital, Capital Medical University
2012.7-2013.7     Senior visiting scholar
University of California, San Diego        
2003- 2012       Assistant Researcher
STD/AIDS Laboratory, Beijing You'an Hospital, Capital Medical University
1999-2000        Resident physician
Shenyang No.1 Hospital
Research Experience:  
1.      Study on Keratin 18 phosphorylation and ASPP2/p53 apoptosis pathway in HBV related chronic liver diseases and hepatocytes apoptosis:
2.      Study on the influence of the human chemokine CCL3L1 on HIV-1 susceptibility:
3.      Research on Mitochondrial toxicity of HIV-1 infected children after antiretroviral therapy:
Grant Supports:
1、“The role of Keratin 18 phosphorylation in HBV infection induced chronic liver diseases and hepatocytes apoptosis”
81100288, National Natural Science Fund of China.
2、“Research of mechanism of ASPP2 supresses HBV replication through inhibits hepatocytes autophagy”
81470098, National Natural Science Fund of China.3、Beijing health system high level health technical personnel Fundation,